Prime Therapeutics - Medicare Specialty Fee Schedule

Effective January 1, 2018

Author: Erica Lawrence/Friday, December 15, 2017/Categories: APCI Choice

This communication serves as notice of Prime Therapeutics LLC (Prime’s) intent to amend the reimbursement terms of the Specialty fee schedules effective January 1, 2018.

If you have any questions regarding the new fee schedules, please contact Prime’s Network Management department at specialtycontracting@primetherapeutics.com or 888.277.5510, option 1.  

Thank you for your continued participation in our pharmacy networks.

Sincerely,

Pharmacy Network Management

Prime Therapeutics LLC

Comments are only visible to subscribers.